74 related articles for article (PubMed ID: 9435099)
1. Synthesis and structural determination of stereoisomers of muscarinic ligands of the (3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicycloalkane type.
Olesen PH; Sauerberg P; Petersen TG; Treppendahl S; Bentzen B; Deeter J; Ward JS; Mitch CH; Lehmann SV
Chirality; 1997; 9(8):739-49. PubMed ID: 9435099
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro muscarinic activities of a series of 3-(pyrazol-3-yl)-1-azabicyclo[2.2.2]octanes.
Plate R; Plaum MJ; van der Hulst RG; de Boer T
Bioorg Med Chem; 2000 Feb; 8(2):449-54. PubMed ID: 10722168
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of (1-azabicyclo[3.3.0]octanyl)methyl-substituted aromatic heterocycles and their muscarinic activity.
Suzuki T; Uesaka H; Hamajima H; Ikami T
Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):876-9. PubMed ID: 10399839
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and muscarinic activities of 3-(pyrazolyl)-1,2,5,6-tetrahydropyridine derivatives.
Plate R; Plaum MJ; de Boer T; Andrews JS; Rae DR; Gibson S
Bioorg Med Chem; 1996 Feb; 4(2):227-37. PubMed ID: 8814880
[TBL] [Abstract][Full Text] [Related]
5. C(8) substituted 1-azabicyclo[3.3.1]non-3-enes and C(8) substituted 1-azabicyclo[3.3.1]nonan-4-ones: novel muscarinic receptor antagonists.
Kim MG; Bodor ET; Wang C; Harden TK; Kohn H
J Med Chem; 2003 May; 46(11):2216-26. PubMed ID: 12747793
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 1-methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine derivatives and their evaluation as muscarinic receptor ligands.
Del Giudice MR; Mustazza C; Borioni A; Gatta F; Tayebati K; Amenta F; Tucci P; Pieretti S
Arch Pharm (Weinheim); 2003 Jun; 336(3):143-54. PubMed ID: 12822179
[TBL] [Abstract][Full Text] [Related]
7. Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane .
Bymaster FP; Shannon HE; Rasmussen K; Delapp NW; Mitch CH; Ward JS; Calligaro DO; Ludvigsen TS; Sheardown MJ; Olesen PH; Swedberg MD; Sauerberg P; Fink-Jensen A
Eur J Pharmacol; 1998 Sep; 356(2-3):109-19. PubMed ID: 9774240
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro muscarinic activities of a series of 1,3-diazacycloalkyl carboxaldehyde oxime derivatives.
Plate R; Jans CG; Plaum MJ; de Boer T
Bioorg Med Chem; 2002 Apr; 10(4):1143-52. PubMed ID: 11836126
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and modeling studies of a potent conformationally rigid muscarinic agonist: 1-azabicyclo[2.2.1]heptanespirofuranone.
Wu ES; Kover A; Semus SF
J Med Chem; 1998 Oct; 41(22):4181-5. PubMed ID: 9784090
[No Abstract] [Full Text] [Related]
11. Synthesis and biological activity of the metabolites of N-[2-(1-azabicyclo[3.3.0]octan-5-yl)ethyl]-2-nitroaniline fumarate (SK-946).
Suzuki T; Inagaki H; Hamajima H; Uesaka H; Hori K; Ikami T
Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):880-3. PubMed ID: 10399840
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonists.
Triggle DJ; Kwon YW; Abraham P; Rahman MA; Carroll FI
Pharm Res; 1992 Nov; 9(11):1474-9. PubMed ID: 1475236
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and cholinergic affinity of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)- pyrrolidine, 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine and of Their iodomethylates.
Dei S; Bellucci C; Buccioni M; Ferraroni M; Gualtieri F; Guandalini L; Manetti D; Matucci R; Romanelli MN; Scapecchi S; Teodori E
Bioorg Med Chem; 2003 Jul; 11(14):3153-64. PubMed ID: 12818678
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.
Tecle H; Barrett SD; Lauffer DJ; Augelli-Szafran C; Brann MR; Callahan MJ; Caprathe BW; Davis RE; Doyle PD; Eubanks D; Lipiniski W; Mirzadegan T; Moos WH; Moreland DW; Nelson CB; Pavia MR; Raby C; Schwarz RD; Spencer CJ; Thomas AJ; Jaen JC
J Med Chem; 1998 Jul; 41(14):2524-36. PubMed ID: 9651157
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice.
Rasmussen T; Sauerberg P; Nielsen EB; Swedberg MD; Thomsen C; Sheardown MJ; Jeppesen L; Calligaro DO; DeLapp NW; Whitesitt C; Ward JS; Shannon HE; Bymaster FP; Fink-Jensen A
Eur J Pharmacol; 2000 Aug; 402(3):241-6. PubMed ID: 10958890
[TBL] [Abstract][Full Text] [Related]
16. Novel enantiopure ferrugininoids active as nicotinic agents: synthesis and radioligand binding studies.
Seifert S; Stehl A; Tilotta MC; Gündisch D; Seitz G
Pharmazie; 2004 Jun; 59(6):427-34. PubMed ID: 15248455
[TBL] [Abstract][Full Text] [Related]
17. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
[TBL] [Abstract][Full Text] [Related]
18. Antagonist binding in the rat muscarinic receptor A study by docking and X-ray crystallography.
Tanczos AC; Palmer RA; Potter BS; Saldanha JW; Howlin BJ
Comput Biol Chem; 2004 Dec; 28(5-6):375-85. PubMed ID: 15556478
[TBL] [Abstract][Full Text] [Related]
19. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
20. Modulation by nicotine on binding of cerebral muscarinic receptors with muscarinic agonist and antagonist.
Wang H; Cui WY; Liu CH
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):497-9. PubMed ID: 9863140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
